Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FU5QN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,161
Award facts
- Contract value 100% obligated
- $24,161.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $24,161.39 delivery order for Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials on August 27, 2025, with completion targeted for August 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The $999.9 billion IDC with DLA serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. This specific delivery order for Ozempic, a diabetes medication, exemplifies the company's role in fulfilling pharmaceutical supply needs across multiple therapeutic domains through DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FU5QN?
SPE2DB25FU5QN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FU5QN worth?
The government has obligated $24,161 on SPE2DB25FU5QN.
Is contract SPE2DB25FU5QN an order under another contract?
Yes. SPE2DB25FU5QN is a delivery order under SPE2DB22D2108, an indefinite delivery contract.
Was contract SPE2DB25FU5QN competed?
The extent of competition for SPE2DB25FU5QN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award